Healthware and FII Tech Growth to boost digital health operations

The round will focus on the development of both Healthware’s core business and the digital health consultancy and product factory activities

Healthware and FII Tech Growth will invest more than €10 million over the next two years to strengthen Healthware’s innovative offering, aimed at improving health outcomes through new technologies.

Healthware is a next-generation integrated consulting group that has been supporting marketing and sales in life sciences through its full-service agency for more than 20 years. It operates at the intersection of the transformation of commercial operations and digital health, offering a unique range of services combining design, strategy, communication and innovation with technology and corporate venturing.

The capital increase will reinforce Healthware’s vertical focusing on business transformation for life sciences companies and product development and services for digital health start-ups.
Focus areas will include digital health platforms, digital therapeutics, health insurance and AI applications.

Healthware and its US-based joint venture partner Intouch Group, represent one of the largest global independent consultancies with a combined team of more than 1,000 dedicated specialists and offices in New York, Boston, Kansas City, Chicago, London, Cologne, Milan, Rome, Salerno and Mumbai.

Roberto Ascione, CEO & Founder of Healthware Group, says:

The health sector has begun a radical digital transformation, perhaps greater than in any other industry. Over the last 20 years Healthware has evolved into a partner able to guide this transformation of life sciences, health tech and health insurance companies, as well as the start-ups that are re-imagining these industries. The partnership with FII Tech Growth will allow us to enhance our ability to work with big companies and start-ups to accelerate their processes and the development of innovative ideas and products.

Mauro Pretolani, Senior Partner of Fondo Italiano d’Investimento SGR, who will join the Board of Healthware Group, declared:

Healthware has the potential to become a global leader in digital health innovation and will play a strategic role in both the Italian and the European healthcare industry. Fondo Italiano d’Investimento is actively committed to Healthware’s development, offering both financial and operational support, in accordance with the investment strategy of FII Tech Growth fund.

Healthware Group

Healthware is a next-generation integrated consulting group that for more than 20 years has been offering large companies and start-ups in the life sciences and insurance sectors a unique set of services and expertise in strategic consulting, communication, technology and innovation, to drive the digital transformation of health.

Founded in Italy, it is led by CEO and founder Roberto Ascione, an international entrepreneur and opinion leader with 20 years of experience in marketing and communication, business process transformation and innovation applied to health.

Healthware, together with its joint venture partner Intouch Group, represents one of the largest independent global player with a combined team of over 1,000 people and a strong international presence with offices in New York, Boston, Kansas City, Chicago, London, Cologne, Milan, Rome, Salerno and Mumbai.

FII Tech Growth

FII Tech Growth, managed by Fondo Italiano d’Investimento SGR, with a target commitment of Euro 150 million, is the first Italian late stage venture capital fund. It is entirely dedicated to equity investments in small and medium-sized technology-based Italian companies, which are either backed by other Venture Capital funds, like Supermercato24 and BeMyEye, or have been self-financed and are owned by entrepreneurs seeking further investment to grow, similarly to SECO and Healthware Group. The fund announced its first closing in September 2017 with Cassa Depositi e Prestiti as cornerstone investor. Fondo Italiano d’Investimento SGR currently manages a total of eight investment funds, dedicated to institutional investors, for a total of about Euro 3 billion of Assets Under Management.


Antonietta Pannella

Healthware Group

Mobile: +39 349 0648276

Roberto Del Giudice

Fondo Italiano d’Investimento SGR

Phone: +39 02 63532.1

Maria Laura Sisti

CSC Vision

Mobile: +39 347 4282170